公开(公告)号：WO1995003009A1

公开(公告)日：1995-02-02

申请号：PCT/US1994007721

申请日：1994-07-14

Applicant: OCULEX PHARMACEUTICALS, INC.

Inventor： OCULEX PHARMACEUTICALS, INC. ,  WONG, Vernon ,  LEE, King ,  GIN, Jerry, B.

IPC: A61F02/00

CPC classification number: A61K38/212 ,  A61K9/0048 ,  A61K9/1647

Abstract: Intraocular administration of drugs such as alpha -2a interferon is employed in the treatment of age-related macular degeneration. Intraocular administration obviates the side effects associated with systemic administration, concentrates the drug at the site of the disease, and, where microcapsules are employed, provides continuous, long-lasting treatment.

Abstract translation: 药物如α-2a干扰素的眼内给药用于治疗年龄相关性黄斑变性。 眼内给药消除与全身给药相关的副作用，将药物浓集在疾病部位，并且在使用微胶囊的地方提供连续的持久治疗。